Identification of putative pathogenic microRNA and its downstream targets in anaplastic lymphoma kinase-negative anaplastic large cell lymphoma

Human Pathology

Volumn 45, Issue 10, 2014, Pages 1995-2005

  Mehrotra, Meenakshi ^a   Medeiros, L Jeffrey ^a   Luthra, Rajyalakshmi ^a   Sargent, Rachel L ^a   Yao, Hui ^a   Barkoh, Bedia A ^a   Singh, Rajesh ^a   Patel, Keyur P ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Anaplastic large cell lymphoma; Expression profiling; In situ hybridization; microRNA; RT PCR

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; MICRORNA; MICRORNA 155; MICRORNA 29A; MICRORNA 29B 1 5P; MICRORNA 720; UNCLASSIFIED DRUG; MIRN155 MICRORNA, HUMAN; PROTEIN TYROSINE KINASE;

ADOLESCENT; ADULT; ARTICLE; CARCINOGENESIS; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LARGE CELL LYMPHOMA; MALE; MICROARRAY ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; BIOSYNTHESIS; DNA MICROARRAY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION; LYMPHOMA, LARGE-CELL, ANAPLASTIC; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR PROTEIN-TYROSINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 84908220408     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2014.06.012     Document Type: Article

References (39)

1. G. Delsol, B. Falini, and H.K. Muller-Hermelink Anaplastic large cell lymphoma (ALCL), ALK-positive S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele, J.W. Vardiman, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008 IARC Lyon 312 316
2. R. Lai, and R.J. Ingham The pathobiology of the oncogenic tyrosine kinase NPM-ALK: a brief update Ther Adv in Hematol 4 2013 119 131
3. M.C. Kinney, R.A. Higgins, and E.A. Medina Anaplastic large cell lymphoma: twenty-five years of discovery Arch Pathol Lab Med 135 2011 19 43
4. L.J. Medeiros, and K.S. Elenitoba-Johnson Anaplastic large cell lymphoma Am J Clin Pathol 127 2007 707 722
5. D.Y. Mason, N.L. Harris, and G. Delsol Anaplastic large cell lymphoma, ALK-negative S.H. Swerdlow, E. Campo, N.L. Harris, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008 IARC Lyon 317 319
6. J.L. Kutok, and J.C. Aster Molecular biology of anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma J Clin Oncol 20 2002 3691 3702
7. A. Wellmann, C. Thieblemont, and S. Pittaluga Detection of differentially expressed genes in lymphomas using cDNA arrays: identification of clusterin as a new diagnostic marker for anaplastic large-cell lymphomas Blood 96 2000 398 404
8. L. Lamant, A. de Reynies, and M.M. Duplantier Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes Blood 109 2007 2156 2164
9. G.A. Calin, and C.M. Croce MicroRNA-cancer connection: the beginning of a new tale Cancer Res 66 2006 7390 7394
10. A.H. Mirnezami, K. Pickard, and L. Zhang MicroRNAs: key players in carcinogenesis and novel therapeutic targets Eur J Surg Oncol 35 2009 339 347
11. S.A. Melo, and M. Esteller Dysregulation of microRNAs in cancer: playing with fire FEBS Lett 585 2011 2087 2099
12. H. Zhao, D. Wang, and W. Du MicroRNA and leukemia: tiny molecule, great function Crit Rev Oncol Hematol 74 2010 149 155
13. J.J. Zhao, J. Lin, and T. Lwin MicroRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma Blood 115 2010 2630 2639
14. G.A. Calin, M. Ferracin, and A. Cimmino A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia N Engl J Med 353 2005 1793 1801
15. T. Donnem, K. Eklo, and T. Berg Prognostic impact of MiR-155 in non-small cell lung cancer evaluated by in situ hybridization J Transl Med 9 2011 6
16. D.W. Mueller, M. Rehli, and A.K. Bosserhoff miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma J Invest Dermatol 129 2009 1740 1751
17. H.G. Drexler, and R.A. MacLeod Malignant hematopoietic cell lines: in vitro models for the study of anaplastic large-cell lymphoma Leukemia 18 2004 1569 1571
18. H. Matsuyama, H.I. Suzuki, and H. Nishimori miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma Blood 118 2011 6881 6892
19. O. Merkel, F. Hamacher, and D. Laimer Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphoma PNAS 107 2010 16228 16233
20. C. Liu, J. Iqbal, and J. Teruya-Feldstein MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma Blood 122 2013 2083 2092
21. P.T. Nelson, and B.R. Wilfred In situ hybridization is a necessary experimental complement to microRNA (miRNA) expression profiling in the human brain Neurosci Lett 466 2009 69 72
22. R. Song, S. Ro, and W. Yan In situ hybridization detection of microRNAs Methods Mol Biol 629 2010 287 294
23. G.K. Smyth Linear models and empirical Bayes methods for assessing differential expression in microarray experiments Stat Appl Genet Mol Biol 3 2004 1544 6115
24. Y. Benjamini, and Y. Hochberg Controlling the false discovery rate - a practical and powerful approach to multiple testing J R Stat Soc Ser B Methodol 57 1995 289 300
25. I. Faraoni, F.R. Antonetti, and J. Cardone miR-155 gene: a typical multifunctional microRNA Biochim Biophys Acta 1792 2009 497 505
26. S.K. Sandhu, C.M. Croce, and R. Garzon Micro-RNA expression and function in lymphomas Adv Hematol 2011 2011 347137
27. Y. Dorsett, K.M. McBride, and M. Jankovic MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation Immunity 28 2008 630 638
28. B. Lamprecht, K. Walter, and S. Kreher Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma Nat Med 16 2010 571 579
29. R. Kumar, J. Manning, and H.E. Spendlove ZNF652, a novel zinc finger protein, interacts with the putative breast tumor suppressor CBFA2T3 to repress transcription Mol Cancer Res 4 2006 655 665
30. R. Holm, S. Knopp, and R. Kumar Expression of ZNF652, a novel zinc finger protein, in vulvar carcinomas and its relation to prognosis J Clin Pathol 61 2008 59 63
31. I. Gomes, T.T. Sharma, and S. Edassery Novel transcription factors in human CD34 antigen-positive hematopoietic cells Blood 100 2002 107 119
32. C.E. Cano, J. Gommeaux, and S. Pietri Tumor protein 53-induced nuclear protein 1 is a major mediator of p53 antioxidant function Cancer Res 69 2009 219 226
33. M. Gironella, M. Seux, and M.J. Xie Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development PNAS 104 2007 16170 16175
34. L. Gonzalez-Cano, A.L. Hillje, and S. Fuertes-Alvarez Regulatory feedback loop between TP73 and TRIM32 Cell Death Dis 4 2013 e704
35. J.A. Ludwig, and J.N. Weinstein Biomarkers in cancer staging, prognosis and treatment selection Nat Rev Cancer 5 2005 845 856
36. B.S. Nielsen, S. Jorgensen, and J.U. Fog High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients Clin Exp Metastasis 28 2011 27 38
37. D. Philippidou, M. Schmitt, and D. Moser Signatures of microRNAs and selected microRNA target genes in human melanoma Cancer Res 70 2010 4163 4173
38. K.L. Kopp, U. Ralfkiaer, and B.S. Nielsen Expression of miR-155 and miR-126 in situ in cutaneous T-cell lymphoma APMIS 121 2013 1020 1024
39. M. Rossing, R. Borup, and R. Henao Down-regulation of microRNAs controlling tumourigenic factors in follicular thyroid carcinoma J Mol Endocrinol 48 2012 11 23